In last trading session, Astera Labs Inc (NASDAQ:ALAB) saw 4.45 million shares changing hands with its beta currently measuring 0.61. Company’s recent per share price level of $60.15 trading at $4.84 or 8.75% at ring of the bell on the day assigns it a market valuation of $9.75B. That closing price of ALAB’s stock is at a discount of -145.04% from its 52-week high price of $147.39 and is indicating a premium of 39.78% from its 52-week low price of $36.22. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 3.66 million shares which gives us an average trading volume of 5.16 million if we extend that period to 3-months.
For Astera Labs Inc (ALAB), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.40. Splitting up the data highlights that, out of 7 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 1 suggested the stock as a Hold whereas 6 see the stock as a Buy. 0 analyst(s) advised it as an Underweight. The company is expected to be making an EPS of 0.28 in the current quarter.
Astera Labs Inc (NASDAQ:ALAB) trade information
Upright in the green during last session for gaining 8.75%, in the last five days ALAB remained trading in the green while hitting it’s week-highest on Wednesday, 04/23/25 when the stock touched $60.15 price level, adding 4.49% to its value on the day. Astera Labs Inc’s shares saw a change of -54.59% in year-to-date performance and have moved 0.12% in past 5-day. Astera Labs Inc (NASDAQ:ALAB) showed a performance of -18.47% in past 30-days. Number of shares sold short was 10.82 million shares which calculate 2.46 days to cover the short interests.
Wall Street analysts have assigned a consensus price target of 102.5 to the stock, which implies a rise of 41.32% to its current value. Analysts have been projecting 100 as a low price target for the stock while placing it at a high target of 110. It follows that stock’s current price would drop -66.25% in reaching the projected high whereas dropping to the targeted low would mean a loss of -66.25% for stock’s current value.
Astera Labs Inc (ALAB) estimates and forecasts
This year revenue growth is estimated to rise 70.39% from the last financial year’s standing.
11 industry analysts have given their estimates about the company’s current quarter revenue by setting an average figure of 151.55M for the same. And 10 analysts are in estimates of company making revenue of 159.53M in the next quarter. Company posted 65.26M and 76.85M of sales in current and next quarters respectively a year earlier.
In 2025, company’s earnings growth rate is likely to be around 50.07% while estimates for its earnings growth in next 5 years are of 43.48%.
Astera Labs Inc (NASDAQ:ALAB)’s Major holders
Insiders are in possession of 15.86% of company’s total shares while institution are holding 69.88 percent of that, with stock having share float percentage of 83.05%. Investors also watch the number of corporate investors in a company very closely, which is 69.88% institutions for Astera Labs Inc that are currently holding shares of the company. FMR LLC is the top institutional holder at ALAB for having 23.35 million shares of worth $1.41 billion. And as of 2024-06-30, it was holding 15.0454 of the company’s outstanding shares.
The second largest institutional holder is INTEL CORP, which was holding about 5.9 million shares on 2024-06-30. The number of shares represents firm’s hold over 3.8036 of outstanding shares, having a total worth of $357.21 million.
On the other hand, VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund and Fidelity Mt. Vernon Street Trust-Fidelity Growth Company Fund are the top two Mutual Funds which own company’s shares. As of Dec 31, 2024 , the former fund manager was holding 3.73 shares of worth $224.51 million or 2.30% of the total outstanding shares. The later fund manager was in possession of 3.4 shares on Feb 28, 2025 , making its stake of worth around $204.48 million in the company or a holder of 2.10% of company’s stock.